No Data
No Data
Minimally Invasive Neurosurgery (02172) rose 8.21% on the Hong Kong stock market connect. Institutions pointed out that the implementation of the DRG/DIP2.0 reform plan is bullish for innovative medical device development.
Jingu Finance News | Micro-invasive Neuroscience (02172) has risen for two consecutive days, with strong gains in early trading. As of the time of publication, it was reported at HKD 8.44, up 8.21%, with a turnover of HKD 6.2349 million. The stock rose 7.44% to HKD 7.8 yesterday. On the news front, the company previously announced its profit forecast, expecting a net income of approximately RMB 0.13 billion to 0.15 billion in the first half of 2024, a year-on-year increase of about 124% to 158%. In other news, Minsheng Securities stated that this DRG/DIP 2.0 grouping plan shows great goodwill towards medical institutions and the industry, and all parties have shown enthusiasm for it in the past three years.
HK stocks surge: Minimally Invasive Neurosurgery (02172) up nearly 5%, with a expected maximum net profit growth of 158% year-on-year in the first half of the year.
Minimally invasive neurology (02172) continues to rise by nearly 5%. As of the time of publication, it has increased by 4.23% to HK$8.13 with a turnover of HK$3.3518 million.
MicroPort NeuroTech Expects Up to 158% Increase in H1 Profit; Stocks Jump Nearly 12%
Hong Kong stocks surged: Minimally Invasive Neurosurgery (02172) opened more than 14%, and it is expected that net profit will increase by about 124% to 158% year-on-year in the first half of the year.
Minimally invasive neurosurgery (02172) opened more than 14%, and as of press time, it has risen by 14.19%, to HKD 8.29, with a turnover of HKD 0.8456 million.
MicroPort NeuroTech Cites Rapid Development of Its Oversea Business >2172.HK
MicroPort NeuroTech Sees 1H Net CNY130M-Net CNY150M, Up 124%-158% on Year >2172.HK
No Data